Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens.
about
Feedback control of glucosamine-6-phosphate synthase GlmS expression depends on the small RNA GlmZ and involves the novel protein YhbJ in Escherichia coliA systems-level approach for investigating Pseudomonas aeruginosa biofilm formationComplicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilisHigh-throughput screening identifies novel inhibitors of the acetyltransferase activity of Escherichia coli GlmU.A passive mutualistic interaction promotes the evolution of spatial structure within microbial populations.Identification and evaluation of twin-arginine translocase inhibitorsApplication of a nanotechnology antimicrobial spray to prevent lower urinary tract infection: a multicenter urology trialComparative Analysis of Xenorhabdus koppenhoeferi Gene Expression during Symbiotic Persistence in the Host Nematode.Inhibitory effects of 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose on biofilm formation by Staphylococcus aureus.Identification and characterization of novel small molecule inhibitors of the acetyltransferase activity of Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU).Structural and functional features of enzymes of Mycobacterium tuberculosis peptidoglycan biosynthesis as targets for drug development.EfaR is a major regulator of Enterococcus faecalis manganese transporters and influences processes involved in host colonization and infection.Strategies for the development of the urinary catheter.Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era.Cytoplasmic steps of peptidoglycan biosynthesis.Staphylococcus epidermidis device-related infections: pathogenesis and clinical management.Peptidoglycan biosynthesis machinery: a rich source of drug targets.Biofilm elimination on intravascular catheters: important considerations for the infectious disease practitioner.New approaches for treating staphylococcal biofilm infections.New strategies to prevent catheter-associated urinary tract infections.ASK2 Bioactive Compound Inhibits MDR Klebsiella pneumoniae by Antibiofilm Activity, Modulating Macrophage Cytokines and Opsonophagocytosis.GlmU (N-acetylglucosamine-1-phosphate uridyltransferase) bound to three magnesium ions and ATP at the active sitePurification and biochemical characterisation of GlmU from Yersinia pestis.Transposase-Mediated Excision, Conjugative Transfer, and Diversity of ICE6013 Elements in Staphylococcus aureus.Effect of DNase and antibiotics on biofilm characteristics.Escherichia coli N-Acetylglucosamine-1-Phosphate-Uridyltransferase/Glucosamine-1-Phosphate-Acetyltransferase (GlmU) Inhibitory Activity of Terreic Acid Isolated from Aspergillus terreus.N-(1-Pyrenyl) maleimide inhibits telomerase activity in a cell free system and induces apoptosis in Jurkat cells.Antibacterial Effects of Chitosan/Cationic Peptide Nanoparticles.
P2860
Q28247175-DFB8BA52-E733-4091-B01D-715213D95FE1Q28486562-13919608-64B4-4981-A865-9CAA724433F8Q30491878-43BE7C92-1F05-4E9A-B86D-B214E6334E89Q33427348-EBD5840B-6018-4FD2-961D-AD14F6AE2C48Q33595748-0B54F671-C64C-40E0-B8B6-B8FB732D4537Q34420325-3F7E6E09-E640-4C4B-8742-D06B6BC8CBC5Q34436765-B1684B1C-652C-4EC7-946E-F3BE35AE0AFBQ34508111-27F1852B-9E7A-4CB1-8C17-66D123EAEAD3Q34737374-FA468A7D-2276-43BC-A9DE-78237DEE6D05Q35840246-126328CC-37B1-482C-98D4-04FB86D840C9Q36319020-776D9A7D-F190-42CA-9D6D-2D53F0B6D31AQ36646710-F40B3891-694B-4CB9-8C98-9F12DE05E2BBQ36759523-F61357E9-0CA8-4B8F-B13D-CEB0936407A4Q36933039-2724DD00-8726-4509-9B16-CC686F472E20Q37081699-8D092550-5334-4FAE-87AF-BE5072464E55Q37322685-F64222B9-72D5-4109-B258-5C5D1AFE7019Q37810971-69EFFD36-0041-4784-921F-57487254780AQ37860818-7D4A24D6-42C9-4310-BFDB-5DE8BFAADF6CQ37970722-83EF3EA1-F0B3-4465-B979-9380BC21668DQ38003089-69113051-9C6E-4C30-8A1E-731B9E61ABDCQ40086229-E6956354-3D2C-487D-933A-4412782E0DD7Q40513738-EF3699D4-1A3B-4995-80AB-CA8CCFBDE360Q41381064-853C85BC-3B17-49C4-B8A8-08EEAA7178D2Q41674625-4CF9B004-1648-4E61-9423-4278746B8894Q41785348-00674527-B619-4B4B-B894-0B75F16AF3D6Q52889316-7305F058-D88F-40F0-B407-7F1F6A670D1DQ54503717-F7DC8705-EE01-4414-A47D-4A4530468273Q55257341-2353070C-325D-45E5-B992-D200EA988FBB
P2860
Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens.
@ast
Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens.
@en
type
label
Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens.
@ast
Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens.
@en
prefLabel
Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens.
@ast
Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens.
@en
P2093
P2860
P1476
Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens.
@en
P2093
Albert D Friesen
Euan Burton
Karen LoVetri
Nandadeva Yakandawala
Srinivasa Madhyastha
Tony Romeo
P2860
P304
P356
10.1128/AAC.50.5.1835-1840.2006
P407
P577
2006-05-01T00:00:00Z